Urdu Version of Kujala Questionnaire: A Reliability and Validity Study
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 1, 2022
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
The original English version of Kujala Questionnaire will be translated and culturally adapted as per previous recommendation. In patients with anterior knee pain or patella femoral knee pain, Kujala Questionnaire-Urdu will be distributed among hundred participants choose a convenience sampling technique based on pre-defined inclusion and exclusion criteria. To test reliability of inter/intra observer of ultimate final Urdu Version of Kujala, 36-Item Short Form Health Survey questionnaire, Lysholm Knee Scoring Scale and 2000 International Knee Documentation Committee Subjective Knee Evaluat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Both genders
- • 2. Ages range from 18-40 years
- • 3. They have clinically diagnosed with patello femoral pain syndrome (the diagnosis was established by a positive patellar grind test and pain on touch sensation, found in medial and lateral patellar facets)
- • 4. Participants who acquire 40 to 80 score on Kujala patellofemoral questionnaire before the treatment start
- • 5. Patients willing to participate.
- Exclusion Criteria:
- • 1. Participants of the study who has gone through any treatment protocol curative measure for patellofemoral pain syndrome during the last 3 months.
- • 2. Any indication or medical record of lower extremity fracture or surgical procedure
- • 3. History of certain chronic disease e.g. Diabetes Mellitus
- • 4. Participants unable to understand Urdu Version of Kujala
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Faisalabad, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Kashif
Study Director
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials